ACHE and Alzheimer disease: Upregulated levels of IL-1β may lead to cognitive impairment associated with AD and an elevation in neuronal acetylcholinesterase expression and activity, resulting in suppression of the synaptic glutaminergic signaling in hippocampal neurons (242–246).